Pliant Therapeutics (PLRX) Receivables (2019 - 2024)
Pliant Therapeutics (PLRX) posted quarterly Receivables of $2.3 million for Q4 2024, down 23.19% year-over-year from $3.0 million in Q1 2024, and down 23.19% quarter-over-quarter from $3.0 million in Q4 2023.
Pliant Therapeutics (PLRX) Receivables (2019 - 2024) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Receivables for 6 consecutive years, with $2.3 million the latest figure, recorded in Q4 2024.
- In Q4 2024, Receivables fell 23.19% year-over-year to $2.3 million; the TTM figure through Dec 2024 stood at $2.3 million (down 23.19% YoY), while the FY2024 annual figure was $2.3 million, down 23.19% from the prior year.
- Receivables eased to $2.3 million in Q4 2024 per PLRX's latest filing, from $3.0 million in the prior quarter.
- Across five years, Receivables topped out at $18.6 million in Q4 2020 and bottomed at $1.6 million in Q3 2021.
- Historically, Receivables has averaged $5.2 million across 5 years, with a median of $3.0 million in 2022.
- Annual changes were most pronounced in 2021 — Receivables tumbled 89.24% — and 2022, when it surged 391.2%.
- Pliant Therapeutics' Receivables stood at $18.6 million in 2020, then sank by 89.24% to $2.0 million in 2021, then soared by 53.05% to $3.1 million in 2022, then declined by 2.09% to $3.0 million in 2023, then fell by 23.19% to $2.3 million in 2024.
- Business Quant data shows PLRX's Receivables at $2.3 million in Q4 2024, $3.0 million in Q4 2023, and $2.0 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 912.74 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 215.33 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.09 Bn |
| 10 | Pliant Therapeutics | 70.59 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.30 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 2.04 Mn |
| Jun 30, 2023 | 3.95 Mn |
| Mar 31, 2023 | 4.67 Mn |
| Dec 31, 2022 | 3.06 Mn |
| Sep 30, 2022 | 5.48 Mn |
| Jun 30, 2022 | 8.99 Mn |
| Mar 31, 2022 | 1.69 Mn |
| Dec 31, 2021 | 2.00 Mn |
| Sep 30, 2021 | 1.61 Mn |
| Jun 30, 2021 | 1.83 Mn |
| Mar 31, 2021 | 2.17 Mn |
| Dec 31, 2020 | 18.58 Mn |
| Sep 30, 2020 | 14.23 Mn |
| Jun 30, 2020 | 7.20 Mn |
| Dec 31, 2019 | 7.10 Mn |